Nano‐biomedicine: Role of nanomaterials in the biomedical sector

Clinical applications of nanosystems require the thorough and precise investigation of biocompatibility, immune response, biodistribution, and side effects. [...]the cost of the products for non-fatal ailments is an affecting factor for the patients whereas for deadly diseases (such as cancer) or pandemic diseases and public health (e.g., severe acute respiratory syndrome coronavirus 2) the cost may not be a crucial factor, especially for developed countries. Intratumoral generation of photothermal gold nanoparticles through a vectorized biomineralization of ionic gold.